Juncai Bai

As Executive Director, Founder, Chairman of the Board & Chief Executive Officer of Ambio Pharmaceuticals, Dr. Bai oversees Ambio, Inc. and AmbioPharm, Inc., covering both USA and China operations. Before joining AmbioPharm, he was the President and CEO of American Peptide Company where he built the cGMP manufacturing business during his tenure.

He was responsible for peptide process development, scale up, and cGMP manufacturing standards. He was involved in numerous peptide process development during his tenure, including the process development and manufacture of a 22-amino acid peptide on a 40kg scale by solution phase chemistry.